These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 30739035

  • 1. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA, Xu Z, Mali SS, Hohmann AG.
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [Abstract] [Full Text] [Related]

  • 2. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA, Saberi SA, Iyer V, Vemuri VK, Makriyannis A, Hohmann AG.
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [Abstract] [Full Text] [Related]

  • 3. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 4. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA, Xu Z, Kulkarni PM, Pertwee RG, Mackie K, Thakur GA, Hohmann AG.
    Biol Psychiatry; 2018 Nov 15; 84(10):722-733. PubMed ID: 28823711
    [Abstract] [Full Text] [Related]

  • 5. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.
    Adamson Barnes NS, Mitchell VA, Kazantzis NP, Vaughan CW.
    Br J Pharmacol; 2016 Jan 15; 173(1):77-87. PubMed ID: 26398331
    [Abstract] [Full Text] [Related]

  • 6. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.
    Anderson WB, Gould MJ, Torres RD, Mitchell VA, Vaughan CW.
    Neuropharmacology; 2014 Jun 15; 81():224-30. PubMed ID: 24384256
    [Abstract] [Full Text] [Related]

  • 7. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW.
    Br J Pharmacol; 2006 Feb 15; 147(3):281-8. PubMed ID: 16331291
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug 15; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 9. Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.
    Sasso O, Bertorelli R, Bandiera T, Scarpelli R, Colombano G, Armirotti A, Moreno-Sanz G, Reggiani A, Piomelli D.
    Pharmacol Res; 2012 May 15; 65(5):553-63. PubMed ID: 22420940
    [Abstract] [Full Text] [Related]

  • 10. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
    Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.
    PLoS One; 2013 May 15; 8(4):e60040. PubMed ID: 23573230
    [Abstract] [Full Text] [Related]

  • 11. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
    Naidu PS, Kinsey SG, Guo TL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2010 Jul 15; 334(1):182-90. PubMed ID: 20375198
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
    Nasirinezhad F, Jergova S, Pearson JP, Sagen J.
    Neuropharmacology; 2015 Aug 15; 95():100-9. PubMed ID: 25486617
    [Abstract] [Full Text] [Related]

  • 13. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L, Kinsey SG, Abdullah RA, Blankman JL, Long JZ, Ezzili C, Boger DL, Cravatt BF, Lichtman AH.
    Br J Pharmacol; 2012 Apr 15; 165(8):2485-96. PubMed ID: 21506952
    [Abstract] [Full Text] [Related]

  • 14. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 15; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 15. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 15; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 15; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 17. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
    Lee WH, Carey LM, Li LL, Xu Z, Lai YY, Courtney MJ, Hohmann AG.
    Mol Pain; 2018 Oct 15; 14():1744806918801224. PubMed ID: 30157705
    [Abstract] [Full Text] [Related]

  • 18. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J, Charron S, Bouchard JF, Beaulieu P.
    Neuropharmacology; 2014 Feb 15; 77():441-52. PubMed ID: 24148808
    [Abstract] [Full Text] [Related]

  • 19. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 15; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 20. Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.
    Zhou Y, Schwartz BI, Giza J, Gross SS, Lee FS, Kreek MJ.
    Psychopharmacology (Berl); 2017 Oct 15; 234(19):2955-2970. PubMed ID: 28730283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.